Tag: CRISPR/Cas9
-
Nation & World
Veteran biotech executive to run new center aimed at boosting cell and gene therapies
Landmark Bio, a new center for advanced cell manufacturing, announced that former Orchard Therapeutics, Amgen, and Genzyme executive Ran Zheng will take over as chief executive. Landmark Bio is a partnership of Boston-area universities, hospitals, and private industry led by Harvard and MIT.
-
Nation & World
From one, many
Harvard research teams systematically profiled every cell in developing zebrafish and frog embryos to establish a roadmap revealing how one cell builds an entire organism.
-
Nation & World
A shot against heart attacks?
Harvard Stem Cell Institute scientists collaborating with researchers at the University of Pennsylvania have developed a “genome-editing” approach for permanently reducing cholesterol levels in mice through a single injection, a development with the potential to reduce the risk of heart attacks in humans by 40 to 90 percent.